KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Year-over-year total asset growth rate
Latest
57.74%
↑ 360% vs avg
Percentile
P87
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
12.54%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 57.74% |
| Q3 2025 | -14.06% |
| Q2 2025 | -9.14% |
| Q1 2025 | 71.60% |
| Q4 2024 | -19.66% |
| Q3 2024 | -14.96% |
| Q2 2024 | 106.55% |
| Q1 2024 | -17.86% |
| Q4 2023 | -13.47% |
| Q3 2023 | -12.48% |
| Q2 2023 | -9.96% |
| Q1 2023 | 24.95% |
| Q4 2022 | -10.69% |
| Q3 2022 | -10.58% |
| Q2 2022 | -9.41% |
| Q1 2022 | -7.69% |
| Q4 2021 | -5.91% |
| Q3 2021 | -4.74% |
| Q2 2021 | 310.86% |
| Q1 2021 | -12.25% |
| Q4 2020 | -10.08% |
| Q3 2020 | -9.32% |
| Q2 2020 | -10.11% |
| Q1 2020 | -8.15% |
| Q4 2019 | -6.52% |
| Q3 2019 | 1.48% |
| Q2 2019 | -6.63% |
| Q1 2019 | -4.55% |
| Q4 2018 | 130.07% |
| Q3 2018 | -6.14% |
| Q2 2018 | -7.90% |
| Q1 2018 | 91.87% |
| Q4 2017 | 12.85% |
| Q3 2017 | -10.37% |
| Q2 2017 | -9.74% |
| Q1 2017 | 6.10% |
| Q3 2016 | -5.64% |
| Q2 2016 | -23.49% |
| Q1 2016 | -12.53% |
| Q4 2015 | -8.52% |